© 1994 Oxford University Press
OTHER |
Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase
Department of Pediatrics, University of Tennessee College of Medicine, and Departments of Immunology and Biochemistry, St Jude Children's Research Hospital Memphis, TN, USA
*To whom correspondence should be addressed at: St Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38105, USA
Received July 26, 1994; Revised August 12, 1994; Accepted August 12, 1994
Mutations in the gene for Bruton's tyrosine kinase (Btk) are responsible for X-linked agammaglobulinemia (XLA). Thus far, mutations in this gene have been identified based on alterations in Southern or Northern blot analysis or cDNA sequence. To permit detection of mutations in genomic DNA, we designed PCR primers to flank each of the 19 exons of Btk with splice sites. Two overlapping PCR products were employed for exons longer than 230 base pairs. Single strand conformation polymorphism (SSCP) analysis was used to screen PCR products from 30 unrelated families presumed to carry a Btk mutation. It was possible to amplify DNA in every reaction from every patient, indicating that large deletions in Btk are uncommon. Twenty three different mutations were found in 25 unrelated families, including one family in whom DNA was available from a carrier but not an affected patient. Seven mutations were single base pair substitutions resulting in premature stop codons scattered throughout the gene. Small insertions or deletions causing frameshifts and secondary premature stop codons constituted an additional seven mutations. One patient had a point mutation in the start codon and one patient had a mutation in a splice donor site. Point mutations resulting in amino acid substitutions were seen in nine patients. Northern blot analysis of RNA from three patients with premature stop codons showed an absence of Btk transcript whereas four patients with amino acid substitutions had normal amounts of transcript of normal size. These studies document the considerable variability in the Btk mutations causing XLA and they demonstrate an approach that will be useful for carrier detection as well as mutation identification.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Yu, A. J. Mohamed, O. E. Simonson, L. Vargas, K. E. M. Blomberg, B. Bjorkstrand, H. J. Arteaga, B. F. Nore, and C. I. E. Smith Proteasome-dependent autoregulation of Bruton tyrosine kinase (Btk) promoter via NF-{kappa}B Blood, May 1, 2008; 111(9): 4617 - 4626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Dobbs, T. Yang, D. Farmer, L. Kager, O. Parolini, and M. E. Conley Cutting Edge: A Hypomorphic Mutation in Igbeta (CD79b) in a Patient with Immunodeficiency and a Leaky Defect in B Cell Development J. Immunol., August 15, 2007; 179(4): 2055 - 2059. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Liu, J. Jelinek, Y. D. Pastore, Y. Guan, J. F. Prchal, and J. T. Prchal Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin Blood, April 15, 2003; 101(8): 3294 - 3301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Vargas, B. F. Nore, A. Berglof, J. E. Heinonen, P. T. Mattsson, C. I. E. Smith, and A. J. Mohamed Functional Interaction of Caveolin-1 with Bruton's Tyrosine Kinase and Bmx J. Biol. Chem., March 8, 2002; 277(11): 9351 - 9357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.-K. Jo, H. Kanegane, S. Nonoyama, S. Tsukada, J.-H. Lee, K. Lim, M. Shong, C.-H. Song, H.-J. Kim, J.-K. Park, et al. Characterization of Mutations, Including a Novel Regulatory Defect in the First Intron, in Bruton's Tyrosine Kinase Gene from Seven Korean X-Linked Agammaglobulinemia Families J. Immunol., October 1, 2001; 167(7): 4038 - 4045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Holinski-Feder, M. Weiss, O. Brandau, K. B. Jedele, B. Nore, C. M. Backesjo, M. Vihinen, S. R. Hubbard, B. H. Belohradsky, C.I. E. Smith, et al. Mutation Screening of the BTK Gene in 56 Families With X-Linked Agammaglobulinemia (XLA): 47 Unique Mutations Without Correlation to Clinical Course Pediatrics, February 1, 1998; 101(2): 276 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kitanaka, H. Mano, M. Ellen Conley, and D. Campana Expression and Activation of the Nonreceptor Tyrosine Kinase Tec in Human B Cells Blood, February 1, 1998; 91(3): 940 - 948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Futatani, T. Miyawaki, S. Tsukada, S. Hashimoto, T. Kunikata, S. Arai, M. Kurimoto, Y. Niida, H. Matsuoka, Y. Sakiyama, et al. Deficient Expression of Bruton's Tyrosine Kinase in Monocytes From X-Linked Agammaglobulinemia as Evaluated by a Flow Cytometric Analysis and Its Clinical Application to Carrier Detection Blood, January 15, 1998; 91(2): 595 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Minegishi, E. Coustan-Smith, Y.-H. Wang, M. D. Cooper, D. Campana, and M. E. Conley Mutations in the Human {lambda}5/14.1 Gene Result in B Cell Deficiency and Agammaglobulinemia J. Exp. Med., January 5, 1998; 187(1): 71 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rohrer and M. Ellen Conley Transcriptional Regulatory Elements Within the First Intron of Bruton's Tyrosine Kinase Blood, January 1, 1998; 91(1): 214 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Yel, Y. Minegishi, E. Coustan-Smith, R. H. Buckley, H. Trubel, L. M. Pachman, G. R. Kitchingman, D. Campana, J. Rohrer, and M. E. Conley Mutations in the Mu Heavy-Chain Gene in Patients with Agammaglobulinemia N. Engl. J. Med., November 14, 1996; 335(20): 1486 - 1493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. S. Rosen, M. D. Cooper, and R. J.P. Wedgwood The Primary Immunodeficiencies N. Engl. J. Med., August 17, 1995; 333(7): 431 - 440. [Full Text] [PDF]
|
|